No Data
No Data
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
JMP Securities analyst David Turkaly maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 39.9% a
OrthoPediatrics Insiders Sold US$768k Of Shares Suggesting Hesitancy
OrthoPediatrics Corp. (NASDAQ:KIDS) shareholders might have a reason to worry after multiple insiders sold their shares over the last year. When evaluating insider transactions, knowing whether insi
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced
OrthoPediatrics Poised for Robust Growth With Strategic Acquisitions and Market Positioning: A Strong Buy Recommendation
OrthoPediatrics Corp Enhances Transparency With Investor Presentations
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2024 Earnings Call Transcript
No Data